Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125796691 | 12579669 | 1 | I | 2014 | 20140113 | 20160721 | 20160721 | PER | US-ASTRAZENECA-2014SE05760 | ASTRAZENECA | 67.00 | YR | M | Y | 99.80000 | KG | 20160721 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125796691 | 12579669 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | U | C175552A | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||
| 125796691 | 12579669 | 2 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 50 | MG | QD | ||||||||
| 125796691 | 12579669 | 3 | SS | BYDUREON | EXENATIDE | 1 | Unknown | FM0258 | 0 | 2 | MG | /wk | |||||||
| 125796691 | 12579669 | 4 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 40 | MG | TABLET | QD | |||||||
| 125796691 | 12579669 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | 150 | UG | QD | ||||||||
| 125796691 | 12579669 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000MG, 1 TABLET IN THE MORNING, HALF OF A TABLET FOR LUNCH, AND A TABLET AT NIGHT. | 0 | TABLET | |||||||||
| 125796691 | 12579669 | 7 | C | CHLORTHALIDONE. | CHLORTHALIDONE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 125796691 | 12579669 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 125796691 | 12579669 | 9 | C | PIOGLITAZONE. | PIOGLITAZONE | 1 | Oral | 0 | 45 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125796691 | 12579669 | 2 | Blood pressure abnormal |
| 125796691 | 12579669 | 3 | Type 2 diabetes mellitus |
| 125796691 | 12579669 | 5 | Thyroid disorder |
| 125796691 | 12579669 | 6 | Thyroid disorder |
| 125796691 | 12579669 | 7 | Diuretic therapy |
| 125796691 | 12579669 | 8 | Blood cholesterol increased |
| 125796691 | 12579669 | 9 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125796691 | 12579669 | Blood glucose increased | |
| 125796691 | 12579669 | Body height decreased | |
| 125796691 | 12579669 | Incorrect dose administered | |
| 125796691 | 12579669 | Injection site swelling | |
| 125796691 | 12579669 | Nodule | |
| 125796691 | 12579669 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125796691 | 12579669 | 1 | 2013 | 0 | ||
| 125796691 | 12579669 | 3 | 2014 | 0 |